Market Analysis
The global antibiotics market was valued USD 31,250.91 Million by 2030 and is likely to grow at a 8.85% CAGR between 2020- 2030, reveals the new Market Research Future (MRFR) report. Antibiotics, simply put, are powerful drugs that fight against bacterial infections. They either destroy bacteria or stop it from reproducing.
Various factors are adding to the global antibiotics market share. These factors, as per the new MRFR report, include favorable government legislation, substantial investments in RD by biotech companies, increasing investments by top companies to create advanced antibiotic products, rising prevalence of infectious and chronic diseases, and development of generic drugs.
On the contrary, the rise in the cost of drug approval and the development of antibiotic resistance may impede the global antibiotics market growth over the forecast period.
Market Segmentation
The Market Research Future Report provides an inclusive segmental analysis of the global antibiotics market based on end user, drug origin, spectrum of activity, and drug class.
By drug class, the global antibiotics market is segmented into sulphonamides, aminoglycosides, carbapenem, macrolides, fluoroquinolones, penicillin, cephalosporins, and others. Of these, the carbapenem drug class segment will lead the market over the forecast period for the rising cases of urinary tract infections pneumonia.
By spectrum of activity, the global antibiotics market is segmented into narrow-spectrum antibiotics and broad-spectrum antibiotics. Of these, the broad-spectrum antibiotic segment will dominate the market over the forecast period as it helps to act against various diseases that help in fighting against microbial resistance.
By drug origin, the global antibiotics market is segmented into synthetic, semisynthetic, and natural. Of these, the semisynthetic segment will have a major share in the market over the forecast period for its higher spectrum of activity and fewer side effects.
By end user, the global antibiotics market is segmented into research organizations, hospitals and clinics, others. Of these, hospitals and clinics will possess the lions share in the market over the forecast period as maximum procedures and treatments are performed in hospitals that increase the use of antibiotics.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/8447
Regional Analysis
Based on the region, the global antibiotics market report covers the recent trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will spearhead the market over the forecast period. Factors adding to the global antibiotics market growth in the region include rising adoption of antibiotics, growing pharmaceutical sector, and increasing cases of infectious diseases.
The global antibiotics market in Europe is predicted to hold the second-largest share over the forecast period for increasing use of generic medicines, rising prevalence of infectious diseases, and increasing consumption of antibiotics.
The global antibiotics market in the APAC region is predicted to grow at the fastest pace over the forecast period. Factors adding to the global antibiotics market growth in the region include the easy accessibility of drugs, increasing sale of OTC (over the counter) drugs, and rising consumption of antibiotics.
The global antibiotics market in the MEA is predicted to have a sound growth over the forecast period for the increasing consumption of antibiotics and rising healthcare expenditure.
Key Players
Key players profiled in the global antibiotics market report include Merck Co., Inc. (US), Eli Lilly and Company (US), Bayer AG (Germany), Sanofi (France), GlaxoSmithKline PLC (UK), Abbott Laboratories (US), Johnson Johnson Services, Inc. (US), Pfizer Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Astellas Pharma Inc. (Japan), Bristol-Myers Squibb Company (US), and Novartis AG (Switzerland).
Industry News
January 2020: Mumbai-based pharmaceutical company Wockhardt is the first Indian company to receive the nod of the drug regulator for two new antibiotics that will be launched soon in the domestic market. These are hospital antibiotics that will be primarily used through the hospital channel to treat critical infections.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/antibiotics-market-8447
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
